Abstract
We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March-May and 58% during June-August 2020. Reasons for decreases and mitigation measures were analysed.
Original language | English |
---|---|
Journal | Eurosurveillance |
Volume | 25 |
Issue number | 47 |
DOIs | |
Publication status | Published - Nov 2020 |